New Treatment Approved in Canada for Gastrointestinal Stromal Tumor
source: pixabay.com

New Treatment Approved in Canada for Gastrointestinal Stromal Tumor

According to a story from Biotech 365, the biopharmaceutical company Deciphera Pharmaceuticals has recently announced that the company's drug ripretinib (marketed as QINLOCK™) has been approved by Health Canada. The…

Continue Reading New Treatment Approved in Canada for Gastrointestinal Stromal Tumor
Study: Nuplazid Demonstrates its Impact in Parkinson’s Disease Patients
source: pixabay.com

Study: Nuplazid Demonstrates its Impact in Parkinson’s Disease Patients

  According to a recent article in Parkinson’s News Today, results of an extension study confirm that FDA approved Nuplazid (pimavanserin) reduces the severity of delusions and hallucinations in Parkinson’s disease…

Continue Reading Study: Nuplazid Demonstrates its Impact in Parkinson’s Disease Patients
Podcast Series Released to Increase Awareness and Education for Nonalcoholic Steatohepatitis
source: pixabay.com

Podcast Series Released to Increase Awareness and Education for Nonalcoholic Steatohepatitis

International Nonalcoholic Steatohepatitis (NASH) Day takes place on June 12th every year. This year, a 4 part podcast series was released by NASHNET as part of the continued effort to spread…

Continue Reading Podcast Series Released to Increase Awareness and Education for Nonalcoholic Steatohepatitis

Perturbations in the Body’s Internal Clock Linked to Greater Risk of Parkinson’s, Study Finds

Older men who have a weak or irregular circadian rhythm — the body’s internal clock that controls the sleep-wake cycle — are approximately three-times more likely to develop Parkinson’s disease…

Continue Reading Perturbations in the Body’s Internal Clock Linked to Greater Risk of Parkinson’s, Study Finds
New Investigative Therapy for Acute Myeloid Leukemia and Myelodysplastic Syndromes is Being Investigated
source: pixabay.com

New Investigative Therapy for Acute Myeloid Leukemia and Myelodysplastic Syndromes is Being Investigated

Antigen-specific T-cell therapy is an innovative treatment option which uses immune cells to combat cancer cells. AdventHealth is the very first in the world to use this treatment for patients…

Continue Reading New Investigative Therapy for Acute Myeloid Leukemia and Myelodysplastic Syndromes is Being Investigated